Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

133.24
-0.7600-0.57%
Post-market: 133.240.00000.00%19:55 EDT
Volume:4.98M
Turnover:665.84M
Market Cap:231.82B
PE:17.30
High:134.97
Open:133.98
Low:133.19
Close:134.00
Loading ...

Abbott Laboratories: Promising Growth Potential with Early CE Mark Approval and Strong PFA Technology Outlook

TIPRANKS
·
28 Mar

Why Abbott Laboratories (ABT) Surged On Thursday?

Insider Monkey
·
28 Mar

Abbott Laboratories Stock Advances 3.7%, Outperforms Competitors

Dow Jones
·
28 Mar

Equity Markets Close Lower on New Auto Tariffs

MT Newswires Live
·
28 Mar

Equity Markets On Track to Close Lower Following Trump's Auto Tariffs

MT Newswires Live
·
28 Mar

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
28 Mar

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
28 Mar

From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets

Benzinga
·
27 Mar

Abbott Laboratories Receives CE Mark Certification for Volt Pulsed Field Ablation System

MT Newswires Live
·
27 Mar

BRIEF-Abbott Receives CE Mark For Its Volt™ Pulsed Field Ablation System To Treat Patients With Abnormal Heart Rhythms

Reuters
·
27 Mar

Abbott Receives Ce Mark for Its Volt™ Pulsed Field Ablation System to Treat Patients With Abnormal Heart Rhythms

THOMSON REUTERS
·
27 Mar

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

PR Newswire
·
27 Mar

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $147 From $154, Maintains Buy Rating

MT Newswires Live
·
27 Mar

Kepler Capital Sticks to Its Buy Rating for Jenoptik (0ZPV)

TIPRANKS
·
27 Mar

Diamond Hill Capital is Crazy About Abbott Laboratories (NYSE:ABT)

Insider Monkey
·
26 Mar

Abbott Hosts Conference Call for First-Quarter Earnings

PR Newswire
·
26 Mar

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income

Motley Fool
·
26 Mar

Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
26 Mar

Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension?

Zacks
·
26 Mar

ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System

Zacks
·
25 Mar